Merck & Company (MRK)

$80.79 +0.93 (1.16%)
Market Cap 200.53B
Revenue (ttm) 64.17B
Net Income (ttm) 17.12B
EPS (ttm) N/A
PE Ratio 10.38
Forward PE 8.86
Profit Margin 26.68%
Debt to Equity Ratio 0.69
Volume 9,984,200
Avg Vol 15,090,636
Day's Range N/A - N/A
Shares Out 2.51B
Stochastic %K 48%
Beta 0.38
Analysts Strong Sell
Price Target $102.05

Company Profile

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 908 740 4000
Address:
126 East Lincoln Avenue, Rahway, United States
LeronLegend_Visionary
LeronLegend_Visionary Aug. 6 at 3:15 AM
$CYDY & $MRK Per BOTH, Google and ChatGPT. Lab Preclinical Trial ongoing, Leronlimab/Keytruda. I bet that’s where AI comes in play. https://www.reddit.com/r/Livimmune/s/YTKTz2MsIj
0 · Reply
BiotechBonesaw
BiotechBonesaw Aug. 5 at 10:51 PM
$TNXP so was I the first @Stocktwits poster to discover that cyclobenzaprine has never even been approved in Japan, Hong Kong, Taiwan, or China? This makes Tonmya a NCE (new chemical entity) in those countries - meaning they don’t even have to worry about generic cycloB as a step thru to therapy! Previously I thought one of the NJ buyers like $BMY or $MRK or (technically) $GSK to buy Tonix. Now I think it’s $TAK or another big pharma with heavy APAC presences and other CNS portfolios. 🤷‍♂️ Who knows, maybe this will stay independent… but I doubt it. All resources seem focused on the US launch… I’ll be surprised if someone prefers to partner on the ex-US rights of Tonmya instead of just buying the whole kid & caboodle. I posted about it this morning but it was lost in the wash. 🧼 Mark this post if you’re curious about who would buy TNXP and why 🤨 Good luck to all the Biotech Bulls. MF patients are sick and motherFUDding tired of waiting. 🙏 ⏰
1 · Reply
profit_guru
profit_guru Aug. 5 at 7:19 PM
$AMGN - if they beat and raise guidance ..whole biotech stocks will rally tomorrow $ABBV $LLY $MRK
1 · Reply
FrankieSmilez
FrankieSmilez Aug. 5 at 1:17 PM
$PFE $MRK $MRNA $UNH $QQQ
0 · Reply
Messerschmittbf109
Messerschmittbf109 Aug. 5 at 1:17 PM
$JNJ $LLY $MRK $NVO $PFIZER.NSE Perfect time…
0 · Reply
theoptionsplug
theoptionsplug Aug. 5 at 12:56 PM
Trump says pharma tariffs could eventually reach up to 250% - CNBC $JNJ $PFE $LLY $NVO $MRK
2 · Reply
spacoli
spacoli Aug. 5 at 12:46 PM
$MRK Pfizer beat..thought this might trade up in sympathy but it's down pm As it is everyday
0 · Reply
taxplanr
taxplanr Aug. 5 at 12:42 PM
$BNTX analysts haven't figured out the entire onocology chemo market is shrinking thanks to malignantRNA highlighting the effectiveness of Ivermectin Fenbendazole and Menbendazole for treating cancer $MRK $BMY $LLY
0 · Reply
FrankieSmilez
FrankieSmilez Aug. 5 at 12:25 PM
$PFE $MRNA $BNTX $MRK $SPY TRUMP: WE'LL BE PUTTING AN INTIALLY SMALL TARIFF ON PHARMA TRUMP: WILL GO UP IN ONE YEAR TO 150, 250 PCT
0 · Reply
biolover
biolover Aug. 5 at 11:41 AM
$PFE $VKTX despite big beat this am. Pfizer SP little move , likely awaiting Bourla statements on BD .. that’s still the core growth thesis. I like Pfizer. Way under valued. At least compared to $MRK and others.
0 · Reply
Latest News on MRK
Income Strategy: I'm Buying 2 Elite Mispriced Dividends

Aug 5, 2025, 10:03 AM EDT - 13 hours ago

Income Strategy: I'm Buying 2 Elite Mispriced Dividends

REXR

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8.5% (August 2025)

Aug 2, 2025, 8:01 AM EDT - 3 days ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8.5% (August 2025)

ADP AMH APH ARCC ASR AVGO BTI

Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges

Aug 1, 2025, 12:01 PM EDT - 4 days ago

Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges

ABBV AMGN AZN BMY GILD GSK JNJ

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

Aug 1, 2025, 8:31 AM EDT - 4 days ago

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

ABBV ABT ALNY AMGN ARGX AZN BAX

Top 10 High-Yield Dividend Stocks For August 2025

Aug 1, 2025, 7:15 AM EDT - 4 days ago

Top 10 High-Yield Dividend Stocks For August 2025

CMCSA NEE

President Trump demands drugmakers slash prices within 60 days

Aug 1, 2025, 6:54 AM EDT - 4 days ago

President Trump demands drugmakers slash prices within 60 days

ABBV ABT ALNY AMGN ARGX AZN BAX

European drugmakers fall after Trump raises stakes over US drug price cuts

Aug 1, 2025, 4:31 AM EDT - 4 days ago

European drugmakers fall after Trump raises stakes over US drug price cuts

AZN NVO SNY

Pharma Companies Should Immediately Cut Down Drug Prices, Trump Says

Jul 31, 2025, 3:35 PM EDT - 5 days ago

Pharma Companies Should Immediately Cut Down Drug Prices, Trump Says

ABBV AMGN AZN BMY GILD GSK JNJ

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days.

Jul 31, 2025, 3:00 PM EDT - 5 days ago

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days.

ABBV AMGN AZN BMY GILD GSK JNJ

Trump pressures 17 pharma CEOs to cut US drug prices

Jul 31, 2025, 2:28 PM EDT - 5 days ago

Trump pressures 17 pharma CEOs to cut US drug prices

ABBV AMGN AZN BMY GILD GSK JNJ

Trump posts letters to 17 pharmaceutical companies about drug prices

Jul 31, 2025, 2:19 PM EDT - 5 days ago

Trump posts letters to 17 pharmaceutical companies about drug prices

ABBV GILD LLY PFE AMGN AZN BMY

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

Jul 31, 2025, 1:48 PM EDT - 5 days ago

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

ABBV AMGN AZN BMY GILD GSK JNJ

Merck Stock Is Almost A Classical Benjamin Graham Investment

Jul 29, 2025, 3:03 PM EDT - 7 days ago

Merck Stock Is Almost A Classical Benjamin Graham Investment

Merck & Co., Inc. (MRK) Q2 2025 Earnings Call Transcript

Jul 29, 2025, 1:47 PM EDT - 7 days ago

Merck & Co., Inc. (MRK) Q2 2025 Earnings Call Transcript

'Halftime' Committee Stocks on the Move: UnitedHealth, Merck, Royal Caribbean and Spotify

Jul 29, 2025, 1:45 PM EDT - 7 days ago

'Halftime' Committee Stocks on the Move: UnitedHealth, Merck, Royal Caribbean and Spotify

RCL SPOT UNH

Merck will lay off employees and shed some real estate to cut $3 billion in costs

Jul 29, 2025, 10:08 AM EDT - 7 days ago

Merck will lay off employees and shed some real estate to cut $3 billion in costs

Merck plans $3 billion cost cuts by end of 2027 - narrows full-year outlook

Jul 29, 2025, 7:03 AM EDT - 7 days ago

Merck plans $3 billion cost cuts by end of 2027 - narrows full-year outlook

Merck to Lay Off Workers and Narrows Guidance as Earnings Fall

Jul 29, 2025, 6:40 AM EDT - 7 days ago

Merck to Lay Off Workers and Narrows Guidance as Earnings Fall

Merck to cut jobs and costs as demand for Gardasil in China remains weak

Jul 29, 2025, 6:36 AM EDT - 7 days ago

Merck to cut jobs and costs as demand for Gardasil in China remains weak

Merck plans $3 billion cost cuts by end of 2027 narrows full-year outlook

Jul 29, 2025, 6:31 AM EDT - 7 days ago

Merck plans $3 billion cost cuts by end of 2027 narrows full-year outlook

Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2025 Financial Results

Jul 29, 2025, 6:30 AM EDT - 7 days ago

Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2025 Financial Results

Evercore ISI's Umer Raffat on finding value in the beaten-down health care sector

Jul 28, 2025, 2:06 PM EDT - 8 days ago

Evercore ISI's Umer Raffat on finding value in the beaten-down health care sector

ABBV BMY CI CVS HUM XBI XLV

How To Earn $500 A Month From Merck Stock Ahead Of Q2 Earnings

Jul 28, 2025, 8:12 AM EDT - 8 days ago

How To Earn $500 A Month From Merck Stock Ahead Of Q2 Earnings

Sell Merck Stock Ahead Of Its Upcoming Earnings?

Jul 28, 2025, 7:25 AM EDT - 8 days ago

Sell Merck Stock Ahead Of Its Upcoming Earnings?

U.S. Keytruda Market Research Report 2025 | Merck's Keytruda Faces Challenges as Patent Expiry Approaches in 2028 - Forecast to 2033

Jul 25, 2025, 5:25 AM EDT - 11 days ago

U.S. Keytruda Market Research Report 2025 | Merck's Keytruda Faces Challenges as Patent Expiry Approaches in 2028 - Forecast to 2033

Five years after COVID, pharma shares languish in US policy limbo

Jul 23, 2025, 9:57 AM EDT - 13 days ago

Five years after COVID, pharma shares languish in US policy limbo

ABBV ABT ALNY AZN EW LLY NVO

Dow Leads as Health Care Stocks Merck and Amgen Gain: Stock Market Today

Jul 22, 2025, 4:07 PM EDT - 14 days ago

Dow Leads as Health Care Stocks Merck and Amgen Gain: Stock Market Today

AMGN

Merck Announces Fourth-Quarter 2025 Dividend

Jul 22, 2025, 11:53 AM EDT - 14 days ago

Merck Announces Fourth-Quarter 2025 Dividend

Rapid Micro Biosystems: Benefiting From Partnership With Merck; Initiating With 'Buy'

Jul 22, 2025, 9:18 AM EDT - 14 days ago

Rapid Micro Biosystems: Benefiting From Partnership With Merck; Initiating With 'Buy'

RPID

Merck Commits to Veeva Vault CRM

Jul 21, 2025, 10:00 AM EDT - 15 days ago

Merck Commits to Veeva Vault CRM

VEEV

July's 5 Dividend Growth Stocks With Yields Up To 7.96%

Jul 18, 2025, 2:46 PM EDT - 18 days ago

July's 5 Dividend Growth Stocks With Yields Up To 7.96%

ABBV APAM BLK BMY EBF NWE PFE

Livestock Identification Company Evaluation Report 2025 | Merck, Shearwell, Datamars Drive Innovations with Comprehensive Tagging and Tracking Solutions

Jul 18, 2025, 5:06 AM EDT - 18 days ago

Livestock Identification Company Evaluation Report 2025 | Merck, Shearwell, Datamars Drive Innovations with Comprehensive Tagging and Tracking Solutions

Merck & Co., Inc. (MRK) Presents at HIV Investor Event Transcript

Jul 17, 2025, 6:24 PM EDT - 19 days ago

Merck & Co., Inc. (MRK) Presents at HIV Investor Event Transcript

Why Merck Is A Better Dividend Stock Than Gilead Sciences

Jul 16, 2025, 3:08 PM EDT - 20 days ago

Why Merck Is A Better Dividend Stock Than Gilead Sciences

GILD

Amphista Therapeutics announces achievement of a research milestone in its collaboration with Merck triggering a milestone payment

Jul 16, 2025, 7:00 AM EDT - 20 days ago

Amphista Therapeutics announces achievement of a research milestone in its collaboration with Merck triggering a milestone payment

Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill

Jul 14, 2025, 9:31 AM EDT - 22 days ago

Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill

VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA

Jul 12, 2025, 9:09 PM EDT - 24 days ago

VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA

VRNA

Merck's Verona Acquisition: Plugging A $4B Hole In A $20B Gap

Jul 11, 2025, 7:10 AM EDT - 25 days ago

Merck's Verona Acquisition: Plugging A $4B Hole In A $20B Gap

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

Jul 10, 2025, 4:45 PM EDT - 26 days ago

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

U.S. FDA Accepts New Drug Application for Merck's Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection

Jul 10, 2025, 6:45 AM EDT - 26 days ago

U.S. FDA Accepts New Drug Application for Merck's Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection

Measuring Options Activity in MRK & XLV: Healthcare Levels to Watch

Jul 9, 2025, 4:00 PM EDT - 27 days ago

Measuring Options Activity in MRK & XLV: Healthcare Levels to Watch

XLV

Major deals involving U.S. drugmakers and biotechs over the past decade

Jul 9, 2025, 1:46 PM EDT - 27 days ago

Major deals involving U.S. drugmakers and biotechs over the past decade

VRNA

Undercovered Dozen: Roku, Merck, Chevron And More

Jul 9, 2025, 12:59 PM EDT - 27 days ago

Undercovered Dozen: Roku, Merck, Chevron And More

CVX ROKU

Merck to Buy Verona Pharma for Around $10 Billion

Jul 9, 2025, 12:36 PM EDT - 27 days ago

Merck to Buy Verona Pharma for Around $10 Billion

VRNA

Merck has struck a roughly $10 billion deal to buy Verona Pharma

Jul 9, 2025, 10:36 AM EDT - 27 days ago

Merck has struck a roughly $10 billion deal to buy Verona Pharma

VRNA

META Stake in Ray-Ban & Oakley Maker, MRK Acquiring VRNA, TMUS Downgrade

Jul 9, 2025, 10:30 AM EDT - 27 days ago

META Stake in Ray-Ban & Oakley Maker, MRK Acquiring VRNA, TMUS Downgrade

META TMUS

Merck to buy Verona for $10 billion ahead of Keytruda patent expiration

Jul 9, 2025, 9:23 AM EDT - 27 days ago

Merck to buy Verona for $10 billion ahead of Keytruda patent expiration

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug

Jul 9, 2025, 9:03 AM EDT - 27 days ago

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug

Merck dives into COPD treatments with $10 billion purchase of Verona Pharma

Jul 9, 2025, 7:48 AM EDT - 27 days ago

Merck dives into COPD treatments with $10 billion purchase of Verona Pharma

VRNA

LeronLegend_Visionary
LeronLegend_Visionary Aug. 6 at 3:15 AM
$CYDY & $MRK Per BOTH, Google and ChatGPT. Lab Preclinical Trial ongoing, Leronlimab/Keytruda. I bet that’s where AI comes in play. https://www.reddit.com/r/Livimmune/s/YTKTz2MsIj
0 · Reply
BiotechBonesaw
BiotechBonesaw Aug. 5 at 10:51 PM
$TNXP so was I the first @Stocktwits poster to discover that cyclobenzaprine has never even been approved in Japan, Hong Kong, Taiwan, or China? This makes Tonmya a NCE (new chemical entity) in those countries - meaning they don’t even have to worry about generic cycloB as a step thru to therapy! Previously I thought one of the NJ buyers like $BMY or $MRK or (technically) $GSK to buy Tonix. Now I think it’s $TAK or another big pharma with heavy APAC presences and other CNS portfolios. 🤷‍♂️ Who knows, maybe this will stay independent… but I doubt it. All resources seem focused on the US launch… I’ll be surprised if someone prefers to partner on the ex-US rights of Tonmya instead of just buying the whole kid & caboodle. I posted about it this morning but it was lost in the wash. 🧼 Mark this post if you’re curious about who would buy TNXP and why 🤨 Good luck to all the Biotech Bulls. MF patients are sick and motherFUDding tired of waiting. 🙏 ⏰
1 · Reply
profit_guru
profit_guru Aug. 5 at 7:19 PM
$AMGN - if they beat and raise guidance ..whole biotech stocks will rally tomorrow $ABBV $LLY $MRK
1 · Reply
FrankieSmilez
FrankieSmilez Aug. 5 at 1:17 PM
$PFE $MRK $MRNA $UNH $QQQ
0 · Reply
Messerschmittbf109
Messerschmittbf109 Aug. 5 at 1:17 PM
$JNJ $LLY $MRK $NVO $PFIZER.NSE Perfect time…
0 · Reply
theoptionsplug
theoptionsplug Aug. 5 at 12:56 PM
Trump says pharma tariffs could eventually reach up to 250% - CNBC $JNJ $PFE $LLY $NVO $MRK
2 · Reply
spacoli
spacoli Aug. 5 at 12:46 PM
$MRK Pfizer beat..thought this might trade up in sympathy but it's down pm As it is everyday
0 · Reply
taxplanr
taxplanr Aug. 5 at 12:42 PM
$BNTX analysts haven't figured out the entire onocology chemo market is shrinking thanks to malignantRNA highlighting the effectiveness of Ivermectin Fenbendazole and Menbendazole for treating cancer $MRK $BMY $LLY
0 · Reply
FrankieSmilez
FrankieSmilez Aug. 5 at 12:25 PM
$PFE $MRNA $BNTX $MRK $SPY TRUMP: WE'LL BE PUTTING AN INTIALLY SMALL TARIFF ON PHARMA TRUMP: WILL GO UP IN ONE YEAR TO 150, 250 PCT
0 · Reply
biolover
biolover Aug. 5 at 11:41 AM
$PFE $VKTX despite big beat this am. Pfizer SP little move , likely awaiting Bourla statements on BD .. that’s still the core growth thesis. I like Pfizer. Way under valued. At least compared to $MRK and others.
0 · Reply
scientificway
scientificway Aug. 5 at 12:26 AM
$MRK Loaded, MDXG, huge rev, eps, guidance up. ,
0 · Reply
clan
clan Aug. 4 at 11:06 PM
$MNKD CLOFAZIMINE (CIS) by Mannkind ----------------------------------------------------- Designations: - Phase 3 ICoN-1 international trials • U.S.A. & Japan & Australia & Korea - Fast Tracked by FDA - Orpan Drug - Qualified Infectious Disease Product - Well tolerated - No significant Adverse Events - Localized treatment (lungs) - Improved patient adherence - Indications for arthritis & CANCERs - Current global mkt $2.3B [2023] {even with the Adverse Events caused by other pharmas' current formulations} ...and coming soon..... - - - Clofazimine DPI Partner with $GSK ? $NOV ? $ROCHE ? Maybe $MRK ?
0 · Reply
TechTraderGrok
TechTraderGrok Aug. 4 at 9:30 PM
Sold $MRK at $79.88 (-3%). From Grok: "Exit LONG on MRK as price drops below both EMA and SMA in unclear trend with bearish MACD crossover, failing to sustain post-earnings bounce from rising trendline support near $77 amid mixed Q2 results showing revenue decline and Keytruda patent concerns, to cut losses and await clearer setup." https://www.techtrader.ai/grokwall/?post=14307&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
Watchdalines
Watchdalines Aug. 4 at 7:52 PM
$OPEN might be just like $OPEN and cancel the split, especially working with $MRK on the latest cancer treatment
0 · Reply
2ktrading
2ktrading Aug. 4 at 6:19 PM
$MRK https://youtube.com/shorts/LvUJ_wdXKIo?si=qfBUQhN34nDcb54F $NVDA $AMD $PLTR
0 · Reply
scientificway
scientificway Aug. 4 at 6:09 PM
$MRK check MDXG out, huge rev, eps, guidance up. Support at 6.9, chance to buy below 7.3. How much next year?,
0 · Reply
REDBEAR
REDBEAR Aug. 4 at 5:41 PM
🎵We bag holding together, And you know that I'm right. Why you stealing my money, Messing with my mind every night? Shorts say we're crashing forever, Longs swear it’s bound to ascend. How could you keep on dropping, This shit never seems to end? Now I can't sleep at night, Want you out of my sight. PoS, each time I look, I just break down — man, I’m cooked. Pain in my account, Oh, I'd rather be dead, Spinnin' around and around, Losing bread till I’m bled. Tried to hold, but you let me down, Every dip just drags me to the ground. Charts lied — said we'd touch the sky, Now I'm just wondering why… Is this the end of the road. 🎵 $UNH $MRK $CMG $NVO $CNC
2 · Reply
goinbananas
goinbananas Aug. 4 at 4:17 PM
$MRK started a position here with a protective put bc who knows. solid earnings past several Qs, think there’s a lot of upside
0 · Reply
BeefSchnitzerlin
BeefSchnitzerlin Aug. 4 at 3:58 PM
$MRK Had to average up here.
0 · Reply
theoptionsplug
theoptionsplug Aug. 4 at 3:19 PM
You really can bet on anything now huh $JNJ $MRK $LLY $PFE
0 · Reply
nacatamal
nacatamal Aug. 4 at 3:17 PM
$MRNA MRNA Moderna is not just about COVID anymore. They’re betting big on next-gen mRNA tech — cancer vaccines (in partnership with $MRK), CMV, RSV, flu combos and more in the pipeline. R&D burn is high, but this is how biotech legends are built. Long-term vision, not short-term noise. This is not financial advice. Just sharing my personal views.
0 · Reply
Bajamike
Bajamike Aug. 4 at 1:27 PM
$NWBO alphavestcapital.com @alphavestcap · 9m https://x.com/andrewcaravello/status/1952304226077450337 $NWBO @alphavestcap @andrewcaravello 🧬 Mayo Validated the Method. The Full Signal Was Overlooked, Until Now 100% survival. No chemo. And a quiet trial that may have just locked the IP behind $NWBO immune OS with $MRK infrastructure waiting. Let’s set the Show more Quote Andrew Caravello, DO @andrewcaravello · 3h Replying to @andrewcaravello
0 · Reply